Off-label use of fixed-dose combination of tramadol and dexketoprofen in primary health care. Evidence-based or cause for concern?
Introduction: The use of the fixed-dose combination of tramadol/dexketoprofen in Spain and in other countries has increased considerably. The authorized therapeutic indication for this medicinal product is the short-term symptomatic treatment of moderate to severe acute pain in adult patients. The o...
Saved in:
Main Authors: | Montserrat Viñas-Bastart (Author), Míriam Oms-Arias (Author), Àfrica Pedraza-Gutiérrez (Author), Irene Lizano-Díez (Author), Eduardo L. Mariño (Author), Pilar Modamio Charles (Author) |
---|---|
Format: | Book |
Published: |
Fundación Pharmaceutical Care España,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Off-label use of fixed-dose combination of tramadol and dexketoprofen in primary health care. Evidence-based or cause for concern?
by: Montserrat Viñas-Bastart, et al.
Published: (2022) -
Tapentadol and Oxycodone/Naloxone Prescribing Patterns in Primary Health Care in Catalonia, Spain: A Cross-Sectional Study
by: Viñas-Bastart M, et al.
Published: (2021) -
Effects of the Off-Label Drug Prescription in the Paediatric Population in Spain from the Adoption of the Latest European Regulation: A Pre-Post Study
by: Irene Lizano-Díez, et al.
Published: (2021) -
Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?
by: Alyssa M Peckham, et al.
Published: (2018) -
Dexketoprofen Pharmacokinetics is not Significantly Altered by Genetic Polymorphism
by: Gina Mejía-Abril, et al.
Published: (2021)